GSK CONSUMER HEALTHCARE HOLDINGS (NO.6) LIMITED

Company number 13401308

Date	Type	Description	View / Download
20 Oct 2023	PSC05	Change of details for Gsk Consumer Healthcare Holdings (No.7) Limited as a person with significant control on 20 October 2023	(2 pages)
17 Oct 2023	AA	Accounts for a dormant company made up to 31 December 2022	(19 pages)
17 Oct 2023	PSC05	Change of details for Gsk Consumer Healthcare Holdings (No.7) Limited as a person with significant control on 18 July 2022	(2 pages)
05 Jun 2023	CH02	Director's details changed for Haleon Uk Corporate Director Limited on 18 July 2022	(1 page)
05 Jun 2023	CH02	Director's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022	(1 page)
23 May 2023	CS01	Confirmation statement made on 8 May 2023 with updates	(4 pages)
17 May 2023	CH02	Director's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023	(1 page)
17 May 2023	CH02	Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 31 March 2023	(1 page)
22 Mar 2023	SH19	Statement of capital on 22 March 2023 GBP 2.665641	(5 pages)
22 Mar 2023	SH20	Statement by Directors	(1 page)
22 Mar 2023	CAP-SS	Solvency Statement dated 14/03/23	(1 page)
22 Mar 2023	RESOLUTIONS	Resolutions RES06 ‐ Resolution of reduction in issued share capital	(2 pages)
03 Oct 2022	AA	Full accounts made up to 31 December 2021	(22 pages)
18 Jul 2022	AD01	Registered office address changed from 980 Great West Road Brentford TW8 9GS England to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022	(1 page)
15 Jun 2022	CS01	Confirmation statement made on 15 May 2022 with updates	(4 pages)
06 Apr 2022	TM01	Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 6 April 2022	(1 page)
06 Apr 2022	TM01	Termination of appointment of the Wellcome Foundation Limited as a director on 6 April 2022	(1 page)
06 Apr 2022	AP02	Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a director on 6 April 2022	(2 pages)
06 Apr 2022	AP02	Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 6 April 2022	(2 pages)
09 Mar 2022	TM01	Termination of appointment of John Michael Sadler as a director on 4 March 2022	(1 page)
09 Mar 2022	AP01	Appointment of Mr Charalampos Panagiotidis as a director on 4 March 2022	(2 pages)
09 Mar 2022	AP01	Appointment of Mrs Roselyne Monique Francoise Cornut as a director on 4 March 2022	(2 pages)
19 Nov 2021	SH19	Statement of capital on 19 November 2021 GBP 266,564.12	(3 pages)
19 Nov 2021	SH20	Statement by Directors	(2 pages)
19 Nov 2021	CAP-SS	Solvency Statement dated 18/11/21	(2 pages)